China Reassures Public On Usage Of Topical Ibuprofen
This article was originally published in PharmAsia News
Executive Summary
Following U.S. FDA's recent warning to eight U.S. manufacturers of topical ibuprofen, China's State FDA has given its assurance that according to China's safety data, the drug does not show serious adverse reactions other than itching, flush and rash